John J Hickey

Title: **The Innovative Contributions of John J Hickey**

Introduction

John J Hickey, an accomplished inventor based in Weymouth, Massachusetts, has made significant contributions to the field of germicidal compositions. With one notable patent to his name, Hickey has demonstrated expertise in blending chemistry and innovation to create effective solutions for germicidal applications.

Latest Patents

Hickey holds a patent for a "Method of forming an iodine based germicide composition." This innovative patent discloses germicidal compositions that consist of iodide anions, a source of peroxide, and peroxidase in conjunction with iodine sequestering agents. The composition is designed to be formed in situ within an aqueous medium through the combination of a peroxide source, iodine ions or their source, a peroxidase classified under Enzyme Commission identification No. E.C. 1.11.1.7, and an iodine sequestrant. A key aspect of this invention is the addition of the sequestrant before the equilibration of the enzymatic reaction, resulting in a non-reactive enzymatic composition. The resulting formulation boasts an increased available iodine concentration compared to similar compositions that lack the iodine sequestrant.

Career Highlights

Hickey’s work with Symbollon Corporation has positioned him as an influential figure in the development of innovative health care solutions. His pioneering work in creating effective germicidal iodine based compositions has the potential to significantly impact public health by enhancing disinfection protocols in various settings.

Collaborations

At Symbollon Corporation, Hickey collaborates with talented professionals like Jack H Kessler and Rick Panicucci. Together, they combine their expertise to drive forward the company's mission of developing advanced health solutions.

Conclusion

John J Hickey's contributions to the field of germicidal compositions reflect his dedication to innovation and public health. His unique patent demonstrates the potential for combining various chemical agents to create more effective germicides. As he continues his work at Symbollon Corporation, the impact of his inventions is likely to be felt widely in the health care sector.